{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:41:06Z","timestamp":1789908066497,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T00:00:00Z","timestamp":1182384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00280-007-0538-0","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T08:09:26Z","timestamp":1182326966000},"page":"809-817","source":"Crossref","is-referenced-by-count":80,"title":["Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice"],"prefix":"10.1007","volume":"61","author":[{"given":"Daniele","family":"Martarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Pompei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,21]]},"reference":[{"key":"538_CR1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.1840190328","volume":"19","author":"RW Ammann","year":"1994","unstructured":"Ammann RW, Ilitsch N, Marincek B, Freiburghaus AU (1994) Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Hepatology 19:735\u2013742","journal-title":"Hepatology"},{"key":"538_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","volume":"12","author":"A Berruti","year":"2005","unstructured":"Berruti A, Terzolo M, Sperone P, Pia A, Casa SD, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L (2005) Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer 12:657\u2013666","journal-title":"Endocr Relat Cancer"},{"key":"538_CR3","first-page":"7247","volume":"62","author":"PD Davis","year":"2002","unstructured":"Davis PD, Dougherty GJ, Blakey DC, Galbraith SM, Tozer GM, Holder AL, Naylor MA, Nolan J, Stratford MR, Chaplin DJ, Hill SA (2002) ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res 62:7247\u20137253","journal-title":"Cancer Res"},{"key":"538_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0001-706X(03)00031-7","volume":"86","author":"AD Dayan","year":"2003","unstructured":"Dayan AD (2003) Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropic 86:141\u2013159","journal-title":"Acta Tropic"},{"key":"538_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","volume":"59","author":"J Fogh","year":"1977","unstructured":"Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221\u2013226","journal-title":"J Natl Cancer Inst"},{"key":"538_CR6","first-page":"5488","volume":"50","author":"A Gazdar","year":"1990","unstructured":"Gazdar A, Oie H, Shackleton C, Chen T, Triche T, Myers C, Chrousos G, Brennan M, Stein C, La Rocca R (1990) Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 50:5488\u20135496","journal-title":"Cancer Res"},{"key":"538_CR7","first-page":"8073","volume":"63","author":"MS Gee","year":"2003","unstructured":"Gee MS, Makonnen S, al-Kofahi K, Roysam B, Payvandi F, Man HW, Muller GW, Lee WM (2003) Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition. Cancer Res 63:8073\u20138078","journal-title":"Cancer Res"},{"key":"538_CR8","first-page":"2559","volume":"82","author":"C Gicquel","year":"1997","unstructured":"Gicquel C, Raffin-Sanson M, Gaston V, Bertagna X, Plouin P, Schlumberger M, Louvel A, Luton J, Le Bouc Y (1997) Structural and functional abnormalities at 11 p 15 are associated with the malignant phenotype in sporadic adrenocortical tumors. Study on a series of 82 tumors. J Clin Endocrinol Metab 82:2559\u20132565","journal-title":"J Clin Endocrinol Metab"},{"key":"538_CR9","first-page":"2212","volume":"51","author":"MA Jordan","year":"1991","unstructured":"Jordan MA, Thrower D, Wilson L (1991) Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 51:2212\u20132222","journal-title":"Cancer Res"},{"key":"538_CR10","first-page":"691","volume":"51","author":"A Leibovitz","year":"1973","unstructured":"Leibovitz A, McCombs WM, Johnston D, McCoy CE, Stinson JC (1973) New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex. J Natl Cancer Inst 51:691\u2013697","journal-title":"J Natl Cancer Inst"},{"key":"538_CR11","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/endo.141.9.7668","volume":"141","author":"A Logie","year":"2000","unstructured":"Logie A, Boudou P, Boccon-Gibod L, Baudin E, Vassal G, Schlumberger M, Le Bouc Y, Gicquel C (2000) Establishment and characterization of a human adrenocortical carcinoma xenograft model. Endocrinology 141:3165\u20133171","journal-title":"Endocrinology"},{"key":"538_CR12","first-page":"2963","volume":"8","author":"T Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay T, Sasaki J, Ramesh R, Roth JA (2002) Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res 8:2963\u20132969","journal-title":"Clin Cancer Res"},{"key":"538_CR13","first-page":"236","volume":"29","author":"E Muller","year":"1982","unstructured":"Muller E, Akovbiantz A, Ammann RW, Bircher J, Eckert J, Wisslerm K, Witassek F, Wuthrich B (1982) Treatment of human echinococcosis with mebendazole. Preliminary observations in 28 patients. Hepatogastroenterology 29:236\u2013239","journal-title":"Hepatogastroenterology"},{"key":"538_CR14","unstructured":"Norton JA (2005) Adrenal tumors. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1528\u20131539"},{"key":"538_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0303-7207(94)90277-1","volume":"100","author":"W Rainey","year":"1994","unstructured":"Rainey W, Bird I, Mason J (1994) NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 100:45\u201350","journal-title":"Mol Cell Endocrinol"},{"key":"538_CR16","first-page":"1201","volume":"1","author":"J Sasaki","year":"2002","unstructured":"Sasaki J, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T (2002) The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther 1:1201\u20131209","journal-title":"Mol Cancer Ther"},{"key":"538_CR17","first-page":"3298","volume":"62","author":"JA Tuxhorn","year":"2002","unstructured":"Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62:3298\u20133307","journal-title":"Cancer Res"},{"key":"538_CR18","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","volume":"72","author":"MD Wooten","year":"1993","unstructured":"Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72:3145\u20133155","journal-title":"Cancer"},{"key":"538_CR19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1517\/13543784.13.9.1171","volume":"13","author":"SL Young","year":"2004","unstructured":"Young SL, Chaplin DJ (2004) Combretastatin A4 phosphate: background and current clinical status. Expert Opin Invest Drugs 13:1171\u20131182","journal-title":"Expert Opin Invest Drugs"},{"key":"538_CR20","first-page":"3222","volume":"59","author":"H Zhiheng","year":"1999","unstructured":"Zhiheng H, Bateman A (1999) Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 59:3222\u20133229","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-007-0538-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-007-0538-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-007-0538-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:06:47Z","timestamp":1559023607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-007-0538-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,21]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s00280-007-0538-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,21]]}}}